[The advantages of depreotide in the diagnosis of spherical solitary pulmonary nodules (SPN): preliminary study].
The affinity of various malignant neoplasms including small cell and non-small cell lung cancer for peptide analogue of somatostatin has been documented. Depreotide is such an analogue and can be combined with technetium--99m (99mTc depreotide) for optical imaging properties. Using this radiopharmaceutical product, solitary pulmonary nodules (SPN) were previously successful evaluated. In this article the preliminary study of the depreotide (NeoSpect--Amersham, Wielka Brytania) in clinical practice has been shown.
Chciałowski
Andrzej
A
Klinika Chorób Wewnetrznych, Pneumonologii i Alergologii Centralnego Szpitala Klinicznego WAM w Warszawie.
Drabek
Ireneusz
I
From
Sławomir
S
Płusa
Tadeusz
T
Dziuk
Eugeniusz
E
Hussein
Naim
N
D000368:Aged; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; D003074:Solitary Pulmonary Nodule / Q000175:diagnosis*; D013004:Somatostatin / Q000031:analogs & derivatives*; D013667:Technetium
D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; D013004:Somatostatin; D013667:Technetium; C444119:technetium Tc 99m depreotide